by Collectif | 22 Mar, 2015 | Bioethics press synthesis | Genome
Clinical trials using “gene editing” or “genetic engineering” techniques are increasing. These techniques use nucleases to modify the genome. Recently, in early March 2015, the Food and Drug Administration (FDA) authorised a phase I...
by Collectif | 19 Mar, 2015 | Bioethics press synthesis
On Wednesday, the management team for the European scientific project, the Human Brain Project (HBP), adopted recommendations made by mediator Wolfang Marquard. In September 2014, the latter was appointed to reform the project in accordance with the wishes of 260...
by Collectif | 19 Mar, 2015 | Bioethics press synthesis | Embryo research and alternatives
Researchers at Osaka University Hospital have succeeded in developing a hybrid nerve cell, which could lead to “less invasive” treatment than the methods currently intended to repair nerve lesions. The team has developed a hybrid cell in mice...
by Collectif | 18 Mar, 2015 | Bioethics press synthesis | All other themes
21 March is World Down Syndrome day. This syndrome is the leading diagnosed cause of mental deficiency of genetic origin. On this occasion, the Famille Chrétienne magazine describes the action taken by the Institut Lejeune including its three missions to...
by Collectif | 18 Mar, 2015 | Bioethics press synthesis | All other themes
As World Down Syndrome Day approaches, questions relating to the incorporation of people with Down Syndrome into society have once again come to the fore. In a paper entitled “Grand angle”, the AFP raises the question of ageing for people with...